- Title
- Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study (vol 26, pg 1, 2022)
- Creators
- Doug W. Gould - Intensive Care National Audit & Research CentreJames Doidge - Intensive Care National Audit & Research CentreM. Zia Sadique - Supreme Council Of HealthMark Borthwick - John Radcliffe HospitalRobert Hatch - Oxford BioMedicaFergus J. Caskey - Renal AssociationLui Forni - University of SurreyRobert F. Lawrence - IntensClare MacEwen - John Radcliffe HospitalMarlies Ostermann - Guy's and St Thomas' NHS Foundation TrustPaul R. Mouncey - Intensive Care National Audit & Research CentreDavid A. Harrison - Intensive Care National Audit & Research CentreKathryn M. Rowan - Intensive Care National Audit & Research CentreJ. Duncan Young - University of OxfordPeter J. Watkinson - Oxford BioMedica
- Publication Details
- Health technology assessment (Winchester, England), Vol.26(13), pp.58-59
- Publisher
- Nihr Journals Library
- Number of pages
- 2
- Date published
- 01/02/2022
- Identifiers
- 99928808602346
- Academic Unit
- School of Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study (vol 26, pg 1, 2022)
Health technology assessment (Winchester, England), Vol.26(13), pp.58-59
01/02/2022
PMID: 35543576
Metrics
1 Record Views